Microtubule arrays in mammalian cells are subject to substantial modulation of both assembly state and dynamics (1) . In cycling cells, microtubule arrays undergo major changes in morphology and stability during mitosis, necessitating changes in the dynamic behavior of individual microtubules (2) (3) (4) .
Microtubules assembled from pure tubulin in vitro can exhibit both spontaneous length fluctuations (5) and treadmilling behavior (6) . Similar dynamic behaviors are observed in vivo but are clearly regulated by cellular metabolism. For example, many studies have shown that microtubule dynamics in cells or in cell extracts are modulated by protein kinase and protein phosphatase activities (7) (8) (9) (10) (11) . In the general case, these enzymes do not act directly on tubulin. Protein kinase regulation of microtubule dynamics is largely mediated through action on other proteins that associate with tubulin dimers or with microtubules (1, 12, 13) . Such proteins can induce microtubule depolymerization or can promote tubulin assembly by stabilizing assembled microtubules. As examples, microtubule depolymerization is favored by the phosphoprotein stathmin, which binds and sequesters tubulin dimers (13) (14) (15) , whereas microtubule stabilization is typically mediated by microtubule-associated proteins (MAPs) that associate with polymers (16) .
The existence of MAPs with potent microtubule-stabilizing activity in dividing cells has been made evident by cell permeabilization experiments (17) . After cell permeabilization, protein kinases are either inhibited or eliminated, and microtubules are resistant to depolymerizing conditions such as dilution of the free tubulin pool and exposure to the microtubule assembly inhibitor nocodazole. Further, in some cell types, including fibroblasts, abundant subsets of microtubules resist exposure to cold temperature.
The microtubule cold stability found in fibroblasts represents an extreme state of polymer stabilization unlikely to be induced by the MAPs identified in cycling cells. These MAPs include E-MAP-115 and MAP4 (18, 19) . MAP4 belongs to the MAP2͞tau family of microtubule-stabilizing proteins that cannot induce microtubule cold stabilization in vitro or in vivo (20, 21) . Overexpression of E-MAP-115 does not induce microtubule cold stability (18) . Further, both MAP4 and E-MAP-115 are present in HeLa epithelial cells, which do not exhibit microtubule cold stability. Certain types of cycling cells thus appear to contain hitherto uncharacterized MAPs with potent microtubule stabilizing properties.
We have isolated from brain tissue a microtubule-binding protein, stable tubule-only polypeptide (STOP), that induces complete microtubule stabilization to various destabilizing agents, including exposure to cold temperature (22) (23) (24) (25) . Despite the apparent neuronal specificity of STOP, its attributes have raised the possibility that MAPs related to STOP may be present in cycling cells exhibiting cold stability (17) .
Herein, we have used NIH 3T3 cells to test this possibility. NIH 3T3 cells are of fibroblastic origin and contain cold-stable microtubules. We demonstrate that these cells contain nonneuronal STOP isoforms and that these isoforms are responsible for the observed microtubule cold stability.
(amino acids 222-240 and 246-267 of the rat brain STOP). Antibodies 136 and 139 were directed against peptides DIKPVK-PIKAKPQYKPPDDK and ATKPDDKEQSKEMNNKLA-EAK, respectively (amino acids 485-504 and 593-613 of the rat brain STOP). Immunized rabbit serum was affinity-purified against the corresponding peptides. mAb 175 (26) is specific of the brain STOP C-terminal repeat motif (C.B., unpublished data).
Cell Culture and Analysis of Protein Extracts. HeLa cells were grown in RPMI 1640 medium containing 10% fetal calf serum (FCS). NIH 3T3 and Rat2 cells were grown in DMEM containing 10% FCS. For total cell extracts, NIH 3T3 cells grown to confluence on 100-mm Petri dishes were scraped in 500 l of boiling 1% SDS and sonicated. For preparation of Triton-soluble cell fractions, NIH 3T3 cells were processed directly or incubated on ice for 30 min before fractionation. Cells were then washed with PBS and extracted for 3 min at the appropriate temperature in 500 l of lysis buffer (17) . For preparation of Triton-insoluble fractions, cells treated as above were subsequently washed with 10 ml of lysis buffer. Cells were then scraped in 500 l of boiling 1% SDS and sonicated. Brain extracts were prepared as described (26) . Protein extracts were then further processed for SDS͞PAGE and Western blotting as described (17) . STOP antibodies were diluted 1:5,000; goat anti-rabbit (Tago) and anti-mouse (Cappel) horseradish peroxidase-coupled secondary antibodies were diluted to 1:5,000.
Microinjection and Immunof luorescence. NIH 3T3 or Rat2 cells, grown on coverslips, were injected with affinity-purified 23N or 23C STOP antibodies at 2 mg͞ml or with nonimmune purified rabbit IgGs at 2 mg͞ml, by using a 5171 micromanipulator and a 5246 transjector (Eppendorf). After a recovery period of 2-16 h, injected cells were directly processed for immunofluorescence or exposed to cold temperature (0°C) for 30 min before processing. Injected cells were fixed in Ϫ20°C methanol and then incubated with anti-␤-tubulin mAb TUB 2.1 (1:100 dilution, Sigma) followed by an incubation with fluorescein isothiocyanate-coupled goat anti-mouse antibody (1:100 dilution, Jackson ImmunoResearch) and Cy3-coupled goat anti-rabbit antibody (1:1,000, Jackson ImmunoResearch).
For double tubulin͞STOP staining, NIH 3T3 or transfected HeLa cells were directly processed for immunofluorescence or cold-treated as above before processing. Cells were permeabilized in lysis buffer for 1 min and further incubated for 1 min in the same buffer containing 10 M paclitaxel (Taxol, Molecular Probes). Cells were fixed in PBS͞4% paraformaldehyde, incubated with mAb TUB 2.1 and affinity-purified STOP 23C antibody (1:50 dilution) and then with secondary antibodies as above. Images were digitalized by using a Princeton RTE-CCD-1317-K͞1 camera (Princeton Instruments, Trenton, NJ) and IPLAB SPECTRUM software (Signal Analytics, Vienna, VA).
Analysis of STOP cDNA and STOP mRNA in NIH 3T3 Cells. cDNA clones of fibroblastic STOPs were obtained by successive screens of an oligo(dT) and random-primed mouse 3T3 gt11 cDNA library (CLONTECH) and of an oligo(dT)-primed mouse 3T3 ZAP II cDNA library (Stratagene), with 32 P-labeled probes derived from rat brain STOP cDNA (25) . Screenings were performed by standard procedures (27) . We obtained a total of 19 positive clones, which were sequenced by Genome Express (Grenoble, France). One clone (16C cDNA) contained the entire sequence coding for another STOP isoform (fibroblastic STOP, F-STOP, see text).
For in vitro translation experiments, the ApaI fragment (nucleotides 1,139-2,470) of 16C cDNA, containing the whole coding sequence, was cloned into pBluescript (Stratagene) to obtain plasmid p16C-Apa. This construct was translated in the TnT-coupled reticulocyte lysate kit (Promega). For cDNA transfection experiments, the SpeI-KpnI fragment of p16C-Apa, containing the ApaI fragment, was subcloned into the expression plasmid putSV1 (Eurogentec, Seraing, Belgium). This construction was used to transfect exponentially growing HeLa cells as described (28) .
RNA analysis by Northern blotting was performed by standard procedures (27) using 32 P-labeled probes derived from 16C cDNA or from STOP genomic clones (see Fig. 2 ).
RESULTS
Immunoblot Analysis and Characterization of STOP Antigens in NIH 3T3 Cells. The nucleotide sequence of mouse brain STOP cDNA (GenBank accession no. Y16008) and the amino acid sequence of mouse brain STOP were deduced from analysis of the four exons of the mouse gene (Mtap6, ref. 29 ). Mouse brain STOP shows extensive homology with rat brain STOP (25) . The protein contains two repeat regions, a central repeat region encoded by exon 1 and a C-terminal repeat region encoded by exon 4 (Fig. 1A) .
We used five STOP antibodies directed against distinct epitopes of the brain protein to probe NIH 3T3 cell extracts for STOP antigens on Western blots. The probes included two antibodies (23C and 23N) directed against two nonoverlapping peptides within the amino acid sequence of the STOP central repeat, two antibodies (136 and 139) that were specific to protein sequences encoded by exons 2 and 3, respectively, and a mAb (mAb 175) recognizing an epitope located in the STOP C-terminal repeat domain ( Fig. 1 A) . NIH 3T3 cell extracts contained a major STOP antigen with an apparent mass of 42 kDa ( Fig. 2A . Compared with the brain STOP cDNA, the 16C cDNA lacked a nucleotide sequence (positions 1-910) corresponding to the 5Ј region of exon 1. The first ATG in the 16C cDNA was at position 1,136. The 16C cDNA also lacked the entire nucleotide stretch corresponding to exon 3. The deletion of exon 3 introduced a frameshift that created a stop codon in exon 4 at nucleotide 2,251 of the cDNA, upstream of the sequences coding for the STOP C-terminal repeats.
Northern blot analysis of NIH 3T3 cell poly(A)
ϩ RNAs using 32 P-labeled 16C cDNA as a probe showed a major band of 2.4 kb (Fig. 2B, lane 1) , similar in size to 16C cDNA. This major NIH 3T3 mRNA hybridized with a probe corresponding to the 3Ј region of exon 1 (Fig. 2B, lane 2) . In contrast, it did not hybridize with probes corresponding either to the 5Ј region of exon 1 or to exon 3 (Fig. 2B, lanes 4 and 6) . Brain STOP mRNA was 3.4 kb long and reacted with all probes (Fig. 2B,  lanes 3, 5, and 7) . These results showed that NIH 3T3 cells contained a major STOP mRNA that was different from brain STOP mRNA but had a domain structure similar to 16C cDNA. This domain structure corroborated the immunoreactivity of F-STOP with the different STOP antibodies (Fig. 1C) . Our data provided strong evidence that we had isolated a cDNA corresponding to the major mRNA, containing the complete coding sequence for F-STOP. In agreement with this conclusion, in vitro translation of the 16C cDNA yielded a protein that comigrated with F-STOP in SDS͞PAGE (Fig.  2C) .
In addition to F-STOP, NIH 3T3 cell extracts contained two minor STOP variants with apparent masses of 48 and 89 kDa, respectively ( Fig. 1 B and C) . Both variants reacted with the two central repeat antibodies (23N and 23C) and with the exon 2 antibody (136). Moreover, the 89-kDa STOP protein reacted with the exon 3 antibody (139) and with mAb 175. We have not further elucidated the structure of the mRNAs coding for these two minor fibroblastic STOP proteins.
Functional Properties and Subcellular Localization of NIH 3T3 Cell STOP Proteins. We have tested whether, despite extensive domain deletions, F-STOP had microtubulestabilizing activity similar to brain STOP. We found that, as brain STOP (25), F-STOP associates with microtubules and induces microtubule cold stabilization when expressed in cells normally devoid of stable polymers (Fig. 3) . This result shows that F-STOP has full microtubule-stabilizing activity in vivo.
With an antibody against the central repeat region (23C), we analyzed the STOP distribution in NIH 3T3 cells. At physiological temperature, STOP staining was barely detectable on the microtubule network (Fig. 4A, row warm) . Remarkably, microtubules in cells exposed to cold temperature before fixation exhibited a bright STOP staining (Fig. 4A, row cold) . These results raised the possibility that cell exposure to cold temperature induced a rapid shift of STOP from the unbound pool onto interphase microtubules. The translocation of STOP to microtubules on cold exposure was further confirmed by immunoblot analysis of Triton-soluble and Triton-insoluble protein fractions from cells exposed or not exposed to the cold prior to assay. The bulk of F-STOP protein was present in the Triton-soluble fraction of untreated cells, but a large proportion of F-STOP had shifted to the Triton-insoluble cell fraction after cold exposure (Fig. 4B) . These results suggest that F-STOP interaction with interphase microtubules is normally inhibited to a large extent by regulatory controls. F-STOP accumulation on the interphase microtubule array in coldtreated cells may reflect an inhibition of these regulatory controls at cold temperature.
STOP regulation is apparently different during mitosis. Examination of STOP distribution in mitotic cells at physio- logical temperature showed a bright staining of spindle microtubules (Fig. 4C, row warm) . This staining was apparently concentrated on kinetochore-to-pole microtubules, whereas astral microtubules were not detectably stained. Exposure of mitotic cells to the cold only moderately enhanced STOP staining on the spindle (Fig. 4C, row cold) . As was shown for cells expressing neuronal STOP (30) , only the STOPassociated kinetochore-to-pole microtubules were resistant to cold temperature.
These results show that STOP proteins are mainly localized in a soluble pool during interphase and are recruited to the interphase microtubule array on exposure to cold temperature. In contrast, STOP is abundant on spindle microtubules at physiological temperature, indicating that it is subject to mitosis-specific regulatory controls.
STOP Proteins Are Responsible for Microtubule Cold Stability in Mammalian Fibroblasts. STOP proteins associate with microtubules in NIH 3T3 cells during cold exposure and present a microtubule stabilizing activity (see above). These results suggest a central role of STOP proteins in the induction of polymer resistance to the cold. However, cold stability could also be conferred on microtubules by other factors. To test whether STOP association with microtubules was indeed responsible for microtubule cold stabilization, we examined the effect of STOP inactivation on microtubule stability in NIH 3T3 cells.
For STOP inactivation, NIH 3T3 cells were injected with affinity-purified 23C STOP antibody. After a recovery period of 2-16 h, cells were either directly fixed or exposed to cold temperature for 30 min before fixation. Cells were then double-stained to detect microinjected STOP antibody and tubulin. Microtubule networks in interphase cells maintained at physiological temperature remained apparently normal after microinjection of the 23C STOP antibody (data not shown). However, when cells were exposed to cold temperature, interphase microtubules in injected cells depolymerized (Fig. 5B) , demonstrating a dramatic loss of microtubule cold stability in the presence of microinjected STOP antibody.
In the present study, STOP antibody microinjection was performed in interphase cells. Some microinjected cells progressed into mitosis during the recovery period after microinjection. Such mitotic cells exhibited apparently normal spindle microtubules when kept at physiological temperature (data not shown). However, spindle microtubules in microinjected mitotic cells showed complete loss of cold stability (Fig. 5D) as compared with noninjected cells (Fig. 5F ). We also observed Microinjection experiments performed with 23N STOP antibody instead of 23C antibody gave identical results both in interphase and mitotic cells. We performed control experiments in which NIH 3T3 cells were microinjected with nonimmune purified rabbit IgGs. Such IgGs had no effect on microtubule stability (data not shown). Finally, when injected in other fibroblastic cells showing extensive microtubule cold stability (Rat2 cells), 23N and 23C STOP antibodies could also abolish microtubule cold stability (data not shown).
Thus, these results show that STOP proteins, although not uniquely required for basic microtubule function in cycling cells at warm temperature, are clearly the principal proteins responsible for microtubule cold stability in these cells. Further, their capacity to associate with microtubules appears to be under cell cycle regulation.
DISCUSSION
Cold stability is a remarkable property of microtubules observed in living cells, in sharp contrast with the lability of microtubules assembled from pure tubulin in vitro. Cold-stable microtubules were initially isolated from mammalian brain extracts (31) and this stability property has been shown to arise from the association of microtubules with a specific MAP, designated STOP (23) (24) (25) . However, microtubule cold stability is not restricted to neuronal cells. It has also been observed in other cell types such as mammalian fibroblasts (17, 32, 33) . A widespread view in the microtubule field has been that microtubule cold stability in dividing cells may result from a complex set of interactions between microtubules and other cell components. For instance, cytoplasmic microtubules are connected to intermediate filaments and this affects their stability (34) . However, the demonstration that STOP alone can induce microtubule cold stability raised the alternative possibility that microtubule cold stability in nonneuronal cells arises from the action of a single class of MAPs related to neuronal STOP. Herein we show that isoforms of STOP are indeed present in NIH 3T3 fibroblasts. These STOP proteins associate with cold-stable microtubules in interphase cells and in the mitotic spindle. Further, STOP inhibition by microinjected STOP antibodies abolishes microtubule cold stability in two fibroblastic cell types. This analysis demonstrates that microtubule cold stability is induced by the association of STOP proteins with microtubules in fibroblasts. We believe that an important implication of these results is that microtubule stability in cells is apparently controlled by a limited number of specific effectors and not by ill-defined cumulative factors. Given the central role of microtubule dynamics in vital cell functions, it seems logical that only a few cell components that are subject to physiological regulation can interfere massively with microtubule stability.
There are major structural differences between STOP proteins in NIH 3T3 cells and the mouse brain STOP. Brain STOP is encoded by four exons. The major NIH 3T3 cell isoform F-STOP contains part of the STOP domain encoded by exon 1 and the STOP domain encoded by exon 2 but elsewhere shows extensive deletions of protein domains compared with brain STOP. Despite such deletions, F-STOP has full microtubule-stabilizing activity in vivo. The absence of exon 1 sequences in the F-STOP mRNA apparently derives from RNA splicing within a nucleotide sequence that is translated in brain. Such RNA splicing within an exon sequence is curious but not unprecedented (35) . We do not know the functional significance of the observed variations of STOP structure between neuronal and fibroblastic cells. An attractive possibility is that the various STOP domains interact with different proteins in a tissue-specific manner. We are currently investigating this possibility.
As STOP is a potent microtubule-stabilizing protein, the generation of active microtubule dynamics in interphase cells must involve rapid regulation of STOP activity. Such regulation is evident from the observation that the bulk of STOP proteins does not bind to microtubules in interphase cells. We have provided (17) evidence that microtubule stability in interphase NIH 3T3 cells was modulated by protein kinases. The apparent inhibition of STOP interaction with microtubules in interphase cells at physiological temperature probably results from STOP phosphorylation by protein kinases, whose activity is inhibited in the cold. Interestingly, STOP proteins accumulate on spindle microtubules both at physiological temperature and in the cold (this study and ref. 30 ). This suggests a role of STOP in the maintenance or function of the mitotic spindle. It is of interest to note that kinetochore-topole microtubules are dynamic, fluxing rapidly poleward (36) , despite their association with STOP proteins.
In microinjection experiments, STOP-antibody-injected cells exhibited apparently normal microtubule arrays in interphase and were capable of progression through mitosis despite extensive inhibition of STOP activity. Thus, STOP function seems largely expendable in cells grown in vitro. This could be anticipated, because certain cycling cells such as HeLa substantially lack STOP proteins (25) and nevertheless show apparently normal microtubular function. One possibility is that STOP function in cultured cells is redundant with that of other MAPs. Precedence for functional redundancy between MAPs was already suggested from inactivation experiments of MAP4 and tau (37, 38) . However, STOP proteins are unique among the MAPs with respect to their microtubule-stabilizing activity and the STOP system may be required for microtubule functions that we have not assayed. One way to look for STOP function at the cellular level will be to search for conditions other than exposure to the cold that induce STOP recruitment on interphase microtubules. Such experiments may reveal hitherto unsuspected function for cytoskeletal stabilization. Other clues to the understanding of STOP function should arise from the elucidation of the molecular identity of STOP regulators and from the study of STOP function in the context of the tissues and organs in which it is expressed. A STOP gene knock-out in mice should thus be of great interest to assess the consequences of STOP inactivation in those tissues that normally contain STOP proteins.
